CW-10201   Click here for help

GtoPdb Ligand ID: 14665

Compound class: Synthetic organic
Comment: CW-10201 is a PROTAC degrader for oncogenic KRAS proteins with G12V/D mutations [1]. It engages the cereblon E3 ligase (CRBN) using the novel high-sffinity, tetracyclic ligand AA-17010 to promote KRAS ubiquitination and proteasomal degradation. KRAS binding is mediated by a derivative of the non-covalent KRASG12D inhibitor MRTX1133.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 16
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 164.44
Molecular weight 1030.14
XLogP 3.01
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC1=C(C=CC2=CC(=CC(=C21)C3=NC=C4C(=C3F)N=C(N=C4N5CCC[C@]6(CCO6)C5)OCC7(CC7)CN8CCC(CC8)(CN9CCC%10(CC9)COC%11=C%10C=C%12C(=C%11)N(C%13CCC(=O)NC%13=O)C(=O)N%12C)F)O)F
Isomeric SMILES FC1=C(C2=CC(O)=CC3=CC=C(F)C(CC)=C32)N=CC4=C(N5CCC[C@]6(CCO6)C5)N=C(OCC7(CC7)CN8CCC(CN9CCC%10(CC9)COC%11=CC%12=C(N(C)C(N%12C%13CCC(NC%13=O)=O)=O)C=C%11%10)(F)CC8)N=C41
InChI InChI=1S/C56H62F3N9O7/c1-3-35-39(57)6-5-33-23-34(69)24-36(45(33)35)47-46(58)48-37(27-60-47)49(67-17-4-9-56(30-67)16-22-75-56)63-51(62-48)74-31-53(10-11-53)28-65-20-14-55(59,15-21-65)29-66-18-12-54(13-19-66)32-73-43-26-42-41(25-38(43)54)64(2)52(72)68(42)40-7-8-44(70)61-50(40)71/h5-6,23-27,40,69H,3-4,7-22,28-32H2,1-2H3,(H,61,70,71)/t40?,56-/m0/s1
InChI Key WOHUMPUYAKVSDD-DSLDWSAXSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
Degrades KRASG12V and KRASG12D with DC50 values of ~4 nM [1]. The cereblon-binding moiety AA-17010, has a Ki of 80 nM, which is ~10 times higher affinity than lenalidomide.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
KRAS Hs None Binding - - - 1
⤷ PROTAC degrader; selectivity for G12V/D KRAS mutants [1]